Publications by authors named "Guillermo E Quintero-Vega"

There is a limited information available on the clinical characteristics, treatment patterns and outcomes on older patients diagnosed with Acute Myeloid Leukemia (AML) in Latin-America. This multicenter retrospective study analyzed 269 patients over 60 years of age diagnosed with AML in Colombia, using data from RENEHOC-PETHEMA registry, from 2009 to 2023. The median age at diagnosis was 70 years (Range:60-98), 55% were men, 61% had an ECOG < 2, and 75.

View Article and Find Full Text PDF
Article Synopsis
  • Systemic therapy for multiple myeloma (MM) has advanced, but access varies widely across Latin America, especially between public and private healthcare sectors.
  • A study involving 1,029 MM patients from five Latin American countries revealed that those in private institutions generally had better prognostic features and treatment options compared to those in public institutions.
  • The median overall survival was lower for patients in public institutions (44.6 months) compared to those in private institutions (53.3 months), highlighting significant disparities in MM management across the region.
View Article and Find Full Text PDF

Cytomegalovirus (CMV) can cause a broad range of diseases, with severity depending on immune status, comorbidities, and age. Initial CMV infection usually occurs in childhood and is typically asymptomatic, leading to lifelong latency. In immunocompromised patients, CMV can affect multiple organs, but salivary gland infections are rare.

View Article and Find Full Text PDF

Introduction/background: Multiple Myeloma (MM) is a plasma cell derived clonal disorder that represents around 1% of all newly diagnosed neoplasms. Limited data regarding MM treatment in Latin America is available, and access to novel agents for a substantial portion of the population is limited by their high costs.

Materials (or Patients) And Methods: RENEHOC is a bidirectional (retrospective and prospective) multicenter observational registry of hematological malignancies in Colombia.

View Article and Find Full Text PDF

Intravascular large B-cell lymphoma (IVLBCL) is a rare subtype of non-Hodgkin lymphoma. It is characterized by the proliferation of cancerous cells into the intraluminal space of the blood vessels. It has a low incidence rate of 0.

View Article and Find Full Text PDF